The increasing prevalence of Coxsackievirus A6 (CVA6) as a major causative agent for Hand, Foot, and Mouth Disease (HFMD) worldwide necessitates the development of an effective vaccine, especially since there is currently no vaccine available against CVA6 infections. CVA6 infections pose a
The memorandum to President Trump suggests addressing the significant need for a cohesive strategy to manage biological risks through the establishment of a Unified National Biosafety and Biosecurity Agency. The driving factor behind this proposal is the potential for high-risk laboratory research
New York State is actively taking proactive steps to prevent and manage Highly Pathogenic Avian Influenza (HPAI) through heightened monitoring and encouraged testing. This initiative aims at early detection to combat the virus, especially given recent HPAI cases recorded in the wild bird population
In a remarkable advancement for the field of biotechnology, McMaster University and Sartorius have inaugurated a state-of-the-art bioprocessing automation laboratory at the university’s Faculty of Engineering, setting a new standard for bioprocess modeling, simulation, and advanced control. This
The field of regenerative medicine is poised to revolutionize healthcare by 2030. With rapid advancements in stem cell therapy, gene therapy, and tissue engineering, this innovative sector offers groundbreaking treatments for a wide array of health conditions. From chronic diseases to injuries and
The US Food and Drug Administration (FDA) raised serious concerns about Sanofi's manufacturing facility in Framingham, Massachusetts, by issuing a Warning Letter for significant deviations from current Good Manufacturing Practice (cGMP) standards for drug substance production. This alarming
